NASDAQ:JYNT - Joint Stock Price, Forecast & News

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Joint Corp (NASDAQ:JYNT) posted its earnings results on Thursday, November, 7th. The company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm earned $12.73 million during the quarter, compared to the consensus estimate of $11.60 million. Joint had a return on equity of 104.54% and a net margin of 6.57%. View Joint's Earnings History.

Joint is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Joint.

Joint updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of for the period. The company issued revenue guidance of $$47.71-48.811 million, compared to the consensus revenue estimate of $$46.32 million.

5 Wall Street analysts have issued twelve-month price objectives for Joint's shares. Their forecasts range from $23.00 to $32.00. On average, they expect Joint's share price to reach $27.00 in the next twelve months. This suggests a possible upside of 64.4% from the stock's current price. View Analyst Price Targets for Joint.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Joint.

News articles about JYNT stock have been trending somewhat positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Joint earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Joint.

Some companies that are related to Joint include TiVo (TIVO), Digital Turbine (APPS), Liberty Tax (TAXA), Quarterhill (QTRHF), Quarterhill (QTRH), Acacia Research (ACTG), Research Frontiers (REFR), Finjan (FNJN), XCel Brands (XELB), XpresSpa Group (XSPA), MGT Capital Investments (MGTI), Marathon Patent Group (MARA), Health Discovery (HDVY), ARC Group (ARCK) and Spherix (SPEX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Advanced Micro Devices (AMD), Starbucks (SBUX), Adobe (ADBE), Catalyst Pharmaceuticals (CPRX), Etsy (ETSY), Lululemon Athletica (LULU), NVIDIA (NVDA), Universal Display (OLED), QUALCOMM (QCOM) and Aurora Cannabis (ACB).

(JYNT) raised $20 million in an IPO on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Joint's stock is owned by a number of of institutional and retail investors. Top institutional investors include Sanders Morris Harris LLC (4.66%), State Street Corp (1.82%), Acadian Asset Management LLC (1.74%), THB Asset Management (1.28%), Goldman Sachs Group Inc. (1.19%) and Cadence Capital Management LLC (0.94%). Company insiders that own Joint stock include Glenn J Krevlin, James H Amos Jr, John P Meloun, Peter D Holt and Ronald V Davella. View Institutional Ownership Trends for Joint.

JYNT stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Granite Investment Partners LLC, Renaissance Technologies LLC, Cadence Capital Management LLC, Russell Investments Group Ltd., Oxford Asset Management LLP, Spark Investment Management LLC and Acadian Asset Management LLC. Company insiders that have sold Joint company stock in the last year include Glenn J Krevlin and Ronald V Davella. View Insider Buying and Selling for Joint.

JYNT stock was bought by a variety of institutional investors in the last quarter, including Sanders Morris Harris LLC, Bank of Montreal Can, Marshall Wace LLP, Globeflex Capital L P, California Public Employees Retirement System, Mesirow Financial Investment Management Inc., Marshall Wace North America L.P. and THB Asset Management. Company insiders that have bought Joint stock in the last two years include James H Amos Jr and Peter D Holt. View Insider Buying and Selling for Joint.

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of JYNT stock can currently be purchased for approximately $16.42.

Joint has a market capitalization of $227.63 million and generates $31.79 million in revenue each year. The company earns $250,000.00 in net income (profit) each year or $0.04 on an earnings per share basis. Joint employs 138 workers across the globe.View Additional Information About Joint.

The official website for Joint is http://www.thejoint.com/.

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at 480-245-5960 or via email at [email protected]